News

Symetis acquires Middle Peak Medical

Details

Symetis has announced the acquisition of Middle Peak Medical. Wellington Partners led the Series A investment into Middle Peak in 2013. 

4SC: overall survival benefit for resminostat in first-line liver cancer study subgroup

Details

Data from a randomized, multi-center, 170 patient Phase II study with resminostat as first-line treatment of advanced liver cancer presented at 2017 Gastrointestinal Cancers Symposium shows substantial increase in overall survival 

immatics and Amgen sign $1B deal

Details

Amgen and Immatics Enter Strategic Collaboration to Develop Novel Bispecific Cancer Immunotherapies 

  1. Themis vector technology featured in quest for Zika vaccine by Top EU-groups
  2. AYOXXA appoints permanent CEO
  3. invendo medical announces CE mark
  4. Chiesi Group acquires Atopix
© Wellington Partners, 2019.